GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

(MedPage Today) -- Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
Cognitive performance at 4.1 years of follow-up was similar in participants...